BioSpace News Archive

Business

Assembly Biosciences Reports Second Quarter 2023 Financial Results and Recent Updates

Assembly Biosciences, Inc., a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, reported financial results and recent updates for the second quarter ended June 30, 2023.

August 9, 2023
·
7 min read
Business

Profound Medical Announces Second Quarter 2023 Financial Results

Profound Medical Corp. reported financial results for the second quarter ended June 30, 2023.

August 9, 2023
·
10 min read
Pharm Country

Acasti to Present GTX-104 Pharmacokinetic Comparison Data at Neurocritical Care Annual Meeting

Acasti Pharma Inc. announced that a poster presenting a pharmacokinetic comparison of GTX-104 with oral nimodipine has been accepted for presentation at the 2023 Neurocritical Care Society annual meeting, to be held in Phoenix, AZ August 15-18, 2023.

August 9, 2023
·
5 min read
Business

Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updates

Gritstone bio, Inc., a clinical-stage biotechnology company working to develop the world’s most potent vaccines, reported financial results for the second quarter ended June 30, 2023 and provided recent corporate and clinical updates.

August 9, 2023
·
12 min read
Business

electroCore Announces Second Quarter 2023 Financial Results

electroCore, Inc., a commercial-stage bioelectronic medicine company and wellness company, announced second quarter 2023 financial results and provided an operational update.

August 9, 2023
·
11 min read
Business

Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 Guidance

Organogenesis Holdings Inc., a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, reported financial results for the second quarter ended June 30th, 2023.

August 9, 2023
·
17 min read
Business

Kamada to Announce Second Quarter and First Half Ended June 30, 2023 Financial Results and Host Conference Call on August 16, 2023

Kamada Ltd. today announced that it will release financial results for the second quarter and first half ended June 30, 2023, prior to the open of the U.S. financial markets on Wednesday, August 16, 2023.

August 9, 2023
·
2 min read
Business

PolyPid Provides Corporate Update and Reports Second Quarter 2023 Financial Results

PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today provided a corporate update and reported financial results for the three and six months ended June 30, 2023.

August 9, 2023
·
10 min read
Business

LENSAR Reports Second Quarter 2023 Results and Provides Business Update

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2023 and provided an update on key operational initiatives.

August 9, 2023
·
15 min read
Biotech Beach

ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing

ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing.

August 9, 2023
·
3 min read